匯川技術(300124.SZ):公司的工業機器人產品在泛3C、光伏、鋰電等行業實現了大批量應用
格隆匯6月27日丨匯川技術(300124.SZ)近期在接待機構調研時表示,公司的工業機器人產品,現在在泛3C、光伏、鋰電等行業實現了大批量應用。無論是工業機器人應用比較成熟的汽車產業鏈,還是基於機器代人趨勢下的勞動密集型產業鏈,都有着對工業機器人產品新增或替代的需求。公司近兩年加速佈局工業機器人產品系列,會加大在自動化各個行業的佈局力度,在客户與產品的高度協同下,實現工業機器人產品在更多行業的突破。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.